Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

509 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 509 results

Early research (Phase 1)Study completedNCT02903069
What this trial is testing

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Who this might be right for
GlioblastomaMalignant Glioma
Celgene 66
Testing effectiveness (Phase 2)Study completedNCT00586508
What this trial is testing

Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

Who this might be right for
Recurrent Glioblastoma
Eli Lilly and Company 81
Testing effectiveness (Phase 2)Ended earlyNCT00848523
What this trial is testing

Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors

Who this might be right for
Recurrent Malignant Gliomas
Neurological Surgery, P.C. 6
Testing effectiveness (Phase 2)Study completedNCT00870181
What this trial is testing

ADV-TK Improves Outcome of Recurrent High-Grade Glioma

Who this might be right for
Malignant Glioma of BrainGlioblastoma
Huazhong University of Science and Technology 47
Not applicableStudy completedNCT01653834
What this trial is testing

Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas

Who this might be right for
Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Large-scale testing (Phase 3)UnknownNCT02629757
What this trial is testing

A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas

Who this might be right for
Anaplastic OligoastrocytomaAnaplastic AstrocytomaGlioblastoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT07376304
What this trial is testing

Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AI

Who this might be right for
Brain Tumor Adult
Hospital del Rio Hortega 100
Not applicableStudy completedNCT00780819
What this trial is testing

Borderzone Sampling

Who this might be right for
High Grade GliomaGlioblastoma
Maastricht University Medical Center 10
Early research (Phase 1)Active Not RecruitingNCT04214392
What this trial is testing

Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma

Who this might be right for
Recurrent GlioblastomaRecurrent Malignant GliomaRecurrent WHO Grade II Glioma+1 more
City of Hope Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06687681
What this trial is testing

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Who this might be right for
Glioma Glioblastoma MultiformeHigh Grade Glioma (III or IV)
Marzieh Ebrahimi 40
Testing effectiveness (Phase 2)Study completedNCT02655601
What this trial is testing

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Who this might be right for
High Grade GliomaAstrocytoma, Grade IIIGlioblastoma
BioMimetix JV, LLC 177
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Testing effectiveness (Phase 2)WithdrawnNCT03649464
What this trial is testing

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Who this might be right for
GlioblastomaAstrocytomaOligodendroglioma
Oblato, Inc.
Not applicableUnknownNCT03370926
What this trial is testing

FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaRadiotherapy
University Hospital, Brest 30
Testing effectiveness (Phase 2)Study completedNCT00458601
What this trial is testing

Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Celldex Therapeutics 82
Testing effectiveness (Phase 2)Ended earlyNCT00014443
What this trial is testing

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Rush University Medical Center 5
Early research (Phase 1)Study completedNCT03011671
What this trial is testing

Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma of Brain
University of Chicago 10
Testing effectiveness (Phase 2)Study completedNCT00064363
What this trial is testing

Talampanel in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00463008
What this trial is testing

Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 12
Load More Results